{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03919578",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Hep B 0218"
      },
      "Organization": {
        "OrgFullName": "PT Bio Farma",
        "OrgClass": "INDUSTRY"
      },
      "BriefTitle": "Protectivity and Safety Following Recombinant Hepatitis B Vaccine",
      "OfficialTitle": "Protectivity and Safety Following Recombinant Hepatitis B Vaccine With Different Source of Hepatitis B Bulk Compared to Hepatitis B (Bio Farma) Vaccine in Indonesian Population"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2020",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 11, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 30, 2020",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "February 28, 2020",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "April 11, 2019",
      "StudyFirstSubmitQCDate": "April 15, 2019",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "April 18, 2019",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 30, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "April 1, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "PT Bio Farma",
        "LeadSponsorClass": "INDUSTRY"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Protectivity and Safety Following Recombinant Hepatitis B Vaccine with different source of Hepatitis B bulk compared to Hepatitis B (Bio Farma) vaccine in Indonesian Population",
      "DetailedDescription": "Protectivity and Safety Following Recombinant Hepatitis B Vaccine with different source of Hepatitis B bulk compared to Hepatitis B (Bio Farma) vaccine in Indonesian Population.\n\nExperimental, randomized, double blind, four arm parallel group study, lot to lot consistency study."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Immunogenicity"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 2",
          "Phase 3"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "Experimental, randomized, double blind, four arm parallel group study",
        "DesignPrimaryPurpose": "Prevention",
        "DesignMaskingInfo": {
          "DesignMasking": "Quadruple",
          "DesignMaskingDescription": "Investigational product was masking with control",
          "DesignWhoMaskedList": {
            "DesignWhoMasked": [
              "Participant",
              "Care Provider",
              "Investigator",
              "Outcomes Assessor"
            ]
          }
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "536",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Hep B Batch 1",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "1 dose of 1 mL Hepatitis B Batch 1",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Recombinant Hepatitis B vaccine"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hep B Batch 2",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "1 dose of 1 mL Hepatitis B Batch 2",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Recombinant Hepatitis B vaccine"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hep B Batch 3",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "1 dose of 1 mL Hepatitis B Batch 3",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Recombinant Hepatitis B vaccine"
              ]
            }
          },
          {
            "ArmGroupLabel": "Hep B (Bio Farma)",
            "ArmGroupType": "Active Comparator",
            "ArmGroupDescription": "1 dose of 1 mL Hepatitis B (Bio Farma)",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Recombinant Hepatitis B (Bio Farma)"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Recombinant Hepatitis B vaccine",
            "InterventionDescription": "Recombinant Hepatitis B vaccine is an inactivated HbsAg produced in yeast cells (Hansenula polymorpha) using recombinant DNA technology. It is a whitish liquid produced by culture genetically engineered yeast cell which carry the relevant gene of the HbsAg. The inactivated HbsAg (bulk) is imported from Serum Institute of India and then formulated and filled at Bio Farma.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hep B Batch 1",
                "Hep B Batch 2",
                "Hep B Batch 3"
              ]
            }
          },
          {
            "InterventionType": "Biological",
            "InterventionName": "Recombinant Hepatitis B (Bio Farma)",
            "InterventionDescription": "Recombinant Hepatitis B vaccine is an inactivated HbsAg produced in yeast cells (Hansenula polymorpha) using recombinant DNA technology. It is a whitish liquid produced by culture genetically engineered yeast cell which carry the relevant gene of the HbsAg. The inactivated HbsAg (bulk) is imported from The Janssen Vaccine Corp and then formulated and filled at Bio Farma.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Hep B (Bio Farma)"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Percentage of subjects with increasing antibody titer >= 4 times",
            "PrimaryOutcomeDescription": "Percentage of subjects with increasing antibody titer >= 4 times: in all subjects; comparison between investigational product and control and between each lot number of Recombinant Hepatitis B",
            "PrimaryOutcomeTimeFrame": "28 days after the last dose immunization"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Geometric Mean Titer (GMT)",
            "SecondaryOutcomeDescription": "GMT in all subjects; comparison of GMT between investigational products and control and comparison of GMT between each lot number of Recombinant Hepatitis B",
            "SecondaryOutcomeTimeFrame": "28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Percentage of subjects with transition of seronegative to seropositive",
            "SecondaryOutcomeDescription": "Percentage of subjects with transition of seronegative to seropositive: in all subjects; Subjets which get investigational products and control and each lot number of Recombinant Hepatitis B",
            "SecondaryOutcomeTimeFrame": "after dosing"
          },
          {
            "SecondaryOutcomeMeasure": "Percentage of subjects with at least one immediate reaction",
            "SecondaryOutcomeDescription": "Immediate reaction (local reaction or systemic event)",
            "SecondaryOutcomeTimeFrame": "30 minutes after each vaccination"
          },
          {
            "SecondaryOutcomeMeasure": "Percentage of subjects with at least one of these adverse events",
            "SecondaryOutcomeDescription": "At least one of these adverse events, expected or not",
            "SecondaryOutcomeTimeFrame": "within 72 hours, between 72 hours to 28 days after vaccination"
          },
          {
            "SecondaryOutcomeMeasure": "Serious adverse event after vaccination",
            "SecondaryOutcomeDescription": "Serious adverse event occurring from inclusion until 28 days after vaccination.",
            "SecondaryOutcomeTimeFrame": "28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Comparison adverse events between Investigational Products (Hepatitis B) and Control",
            "SecondaryOutcomeDescription": "Adverse events occuring until 28 days after vaccination",
            "SecondaryOutcomeTimeFrame": "28 days"
          },
          {
            "SecondaryOutcomeMeasure": "Comparison of adverse events between each lot number of Recombinant Hepatitis B vaccine",
            "SecondaryOutcomeDescription": "Adverse events occuring until 28 days after vaccination",
            "SecondaryOutcomeTimeFrame": "28 days"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nHealthy individu as determined by clinical judgment, including a medical history and physical exam which confirms the absence of a current or past disease state considered significant by the investigator.\nSubjects/parents/guardian(s) have been informed properly regarding the study and signed the informed consent form/ informed assent form.\nSubject/parents/guardian(s) will commit to comply with the instructions of the investigator and the schedule of the trial.\n\nExclusion Criteria:\n\nSubject concomitantly enrolled or scheduled to be enrolled in another trial.\nSubjects with known history of Hepatitis B contained vaccination in the last 10 years\nEvolving severe illness and/or chronic disease and fever (axillary temperature more than37.5oC) within the 48 hours preceding enrollment.\nKnown history of allergy to any component of the vaccines (based on anamnesis)\nHBsAg positive\nKnown history of immunodeficiency disorder (HIV infection, leukemia, lymphoma, or malignancy).\nHistory of uncontrolled coagulopathy or blood disorders contraindicating intramuscular injection.\nSubject who has received in the previous 4 weeks a treatment likely to alter the immune response (intravenous immunoglobulins, blood-derived products or corticosteroid therapy and other immunosuppresant.\nPregnancy & Lactation (Adult)\nSubject already immunized with any vaccine within 4 weeks prior and expects to receive other vaccines within 4 weeks following immunization.",
      "HealthyVolunteers": "Accepts Healthy Volunteers",
      "Gender": "All",
      "MinimumAge": "10 Years",
      "MaximumAge": "40 Years",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Yetty M Nency, MD",
            "OverallOfficialAffiliation": "Universitas Diponegoro",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "RSND",
            "LocationCity": "Semarang",
            "LocationState": "Central Java",
            "LocationCountry": "Indonesia"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000006509",
            "ConditionMeshTerm": "Hepatitis B"
          },
          {
            "ConditionMeshId": "D000006505",
            "ConditionMeshTerm": "Hepatitis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000008107",
            "ConditionAncestorTerm": "Liver Diseases"
          },
          {
            "ConditionAncestorId": "D000004066",
            "ConditionAncestorTerm": "Digestive System Diseases"
          },
          {
            "ConditionAncestorId": "D000086982",
            "ConditionAncestorTerm": "Blood-Borne Infections"
          },
          {
            "ConditionAncestorId": "D000003141",
            "ConditionAncestorTerm": "Communicable Diseases"
          },
          {
            "ConditionAncestorId": "D000007239",
            "ConditionAncestorTerm": "Infections"
          },
          {
            "ConditionAncestorId": "D000018347",
            "ConditionAncestorTerm": "Hepadnaviridae Infections"
          },
          {
            "ConditionAncestorId": "D000004266",
            "ConditionAncestorTerm": "DNA Virus Infections"
          },
          {
            "ConditionAncestorId": "D000014777",
            "ConditionAncestorTerm": "Virus Diseases"
          },
          {
            "ConditionAncestorId": "D000006525",
            "ConditionAncestorTerm": "Hepatitis, Viral, Human"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M8747",
            "ConditionBrowseLeafName": "Hepatitis B",
            "ConditionBrowseLeafAsFound": "Hepatitis B",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8743",
            "ConditionBrowseLeafName": "Hepatitis",
            "ConditionBrowseLeafAsFound": "Hepatitis",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M8744",
            "ConditionBrowseLeafName": "Hepatitis A",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10259",
            "ConditionBrowseLeafName": "Liver Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8035",
            "ConditionBrowseLeafName": "Gastrointestinal Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6407",
            "ConditionBrowseLeafName": "Digestive System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M9435",
            "ConditionBrowseLeafName": "Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M5520",
            "ConditionBrowseLeafName": "Communicable Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M19640",
            "ConditionBrowseLeafName": "Hepadnaviridae Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16674",
            "ConditionBrowseLeafName": "Virus Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6594",
            "ConditionBrowseLeafName": "DNA Virus Infections",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M8762",
            "ConditionBrowseLeafName": "Hepatitis, Viral, Human",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC01",
            "ConditionBrowseBranchName": "Infections"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC06",
            "ConditionBrowseBranchName": "Digestive System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M16512",
            "InterventionBrowseLeafName": "Vaccines",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}